Table 3.
Genotype | Treatment | n | pHa | , mmHg | , mmHg | Hemoglobin, mg/dl | Base Excess, mmol/l |
---|---|---|---|---|---|---|---|
Ndufs4+/+ | Saline | 9 | 7.32 ± 0.02 | 335 ± 33 | 32 ± 3 | 10.8 ± 0.6 | −8 ± 1.5 |
Ndufs4−/− | Saline | 8 | 7.21 ± 0.03b | 156 ± 20b | 38 ± 3 | 11.6 ± 0.5 | −11.3 ± 1.5 |
Ndufs4+/+ | DMSO 100% (0.5 ml/kg) | 8 | 7.32 ± 0.02 | 352 ± 38 | 34 ± 3 | 11.1 ± 0.3 | −7.6 ± 1.6 |
Ndufs4+/+ | Piericidin A (0.5 mg/kg) | 7 | 7.28 ± 0.02 | 163 ± 32a,b | 30 ± 1 | 10.6 ± 0.3 | −11.6 ± 1.4 |
Ndufs4+/+ | After 3 wk at 0.11 | 7 | 7.22 ± 0.02a | 269 ± 36 | 30 ± 2 | 16 ± 0.8a | −14.5 ± 1.1a |
Ndufs4−/− | After 3 wk at 0.11 | 7 | 7.14 ± 0.02a | 336 ± 26 | 31 ± 1 | 15.1 ± 0.6a | −17.8 ± 1a |
Values are means ± SE. Each parameter was analyzed in each group by ANOVA with a post hoc correction for multiple comparisons. , fraction of inspired oxygen; , partial pressure of arterial carbon dioxide; , partial pressure of arterial oxygen.
P < 0.05 vs. saline-treated Ndufs4+/+ mice;
P < 0.05 vs. Ndufs4+/+ mice in the same treatment group.